PMID- 26949603 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160307 LR - 20200929 IS - 2222-3959 (Print) IS - 2227-4898 (Electronic) IS - 2222-3959 (Linking) VI - 9 IP - 1 DP - 2016 TI - Inhibition of zymosan-induced cytokine and chemokine expression in human corneal fibroblasts by triptolide. PG - 9-14 LID - 10.18240/ijo.2016.01.02 [doi] AB - AIM: To investigate the effects of triptolide on proinflammatory cytokine and chemokine expression induced by the fungal component zymosan in cultured human corneal fibroblasts (HCFs). METHODS: HCFs were cultured in the absence or presence of zymosan or triptolide. The release of interleukin (IL)-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1) into culture supernatants was measured with enzyme-linked immunosorbent assays. The cellular abundance of the mRNAs for these proteins was determined by reverse transcription and real-time polymerase chain reaction analysis. The phosphorylation of mitogen-activated protein kinases (MAPKs) and the endogenous nuclear factor-kappaB (NF-kappaB) inhibitor IkappaB-alpha was examined by immunoblot analysis. The release of lactate dehydrogenase (LDH) activity from HCFs was measured with a colorimetric assay. RESULTS: Triptolide inhibited the zymosan-induced release of IL-6, IL-8, and MCP-1 from HCFs in a concentration- and time-dependent manner. It also inhibited the zymosan-induced up-regulation of IL-6, IL-8, and MCP-1 mRNA abundance in these cells. Furthermore, triptolide attenuated zymosan-induced phosphorylation of the MAPKs extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 as well as the phosphorylation and degradation of IkappaB-alpha. Triptolide did not exhibit cytotoxicity for HCFs. CONCLUSION: Triptolide inhibited proinflammatory cytokine and chemokine production by HCFs exposed to zymosan, with this action likely being mediated by suppression of MAPK and NF-kappaB signaling pathways. This compound might thus be expected to limit the infiltration of inflammatory cells into the cornea associated with fungal infection. FAU - Liu, Yang AU - Liu Y AD - Department of Ophthalmology, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. FAU - Li, Jing AU - Li J AD - Department of Ophthalmology, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. FAU - Liu, Ye AU - Liu Y AD - Department of Pathology, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. FAU - Wang, Ping AU - Wang P AD - Department of Otolaryngology-Head and Neck Surgery, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. FAU - Jia, Hui AU - Jia H AD - Department of Ophthalmology, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. LA - eng PT - Journal Article DEP - 20160118 PL - China TA - Int J Ophthalmol JT - International journal of ophthalmology JID - 101553860 PMC - PMC4768509 OTO - NOTNLM OT - corneal fibroblast OT - fungal keratitis OT - inflammation OT - triptolide OT - zymosan EDAT- 2016/03/08 06:00 MHDA- 2016/03/08 06:01 PMCR- 2016/01/18 CRDT- 2016/03/08 06:00 PHST- 2015/01/26 00:00 [received] PHST- 2015/04/27 00:00 [accepted] PHST- 2016/03/08 06:00 [entrez] PHST- 2016/03/08 06:00 [pubmed] PHST- 2016/03/08 06:01 [medline] PHST- 2016/01/18 00:00 [pmc-release] AID - ijo-09-01-009 [pii] AID - 10.18240/ijo.2016.01.02 [doi] PST - epublish SO - Int J Ophthalmol. 2016 Jan 18;9(1):9-14. doi: 10.18240/ijo.2016.01.02. eCollection 2016.